Star Health and Allied Insurance reported a 13% increase in insurance revenue to ₹4,920 crore for the first quarter of FY27. The company's profitability improved as it saw a 47% rise in insurance service results compared to the same period last year. This performance was supported by better claims management and an improved combined ratio, which measures underwriting profitability and operational costs.
Star Health and Allied Insurance Company Limited recorded steady financial growth in the first quarter of the 2027 fiscal year. The company reported insurance revenue of ₹4,920 crore, marking a 13% rise from the previous year. This growth was matched by a 19% increase in gross premium collections, highlighting the insurer's success in acquiring new customers and expanding its footprint in the health insurance market.
A key focus for investors this quarter is the company's transition to Ind-AS accounting standards, which changes how financial results are presented. Despite this shift, the insurer managed to improve its insurance service results to ₹420 crore, a 47% increase compared to the same period last year. This result reportedly came in ahead of some market expectations, largely due to tighter control over operational expenses and effective management of health insurance claims.
Efficiency and Underwriting Performance
The combined ratio, a critical metric for insurance companies that tracks the relationship between claims paid and administrative expenses against premiums collected, showed improvement. During the quarter, Star Health reported a combined ratio of 97%, which is 170 basis points better than the previous year. A lower combined ratio generally indicates that an insurer is becoming more efficient at underwriting policies and managing its costs relative to the premiums it earns.
Context and Investor Monitorables
While the company has shown improvements in its core underwriting operations, the health insurance sector remains competitive. The primary factors that investors typically watch in this industry include the sustainability of premium growth and the ability to keep claims ratios stable over time. Changes in healthcare costs and hospital network agreements can directly impact the profitability of health insurers.
Following these quarterly results, Motilal Oswal has maintained a positive outlook on the stock, setting a price target of ₹770 based on earnings estimates for FY28. However, investors should remain aware that these estimates are based on projections and the final outcomes will depend on the company's ability to maintain these margins amidst sector-wide competition. Moving forward, the key items for investors to track will be the consistency of the combined ratio improvement and whether the company can sustain its growth in gross premiums without significantly increasing its acquisition costs.